Hydroxycitric acid inhibits oxalate nephropathies formation through crystallization regulation and activation of the PPARα pathway https://www.biorxiv.org/content/10.1101/2022.12.05.519215v1?med=mas
Hydroxycitric acid inhibits oxalate nephropathies formation through crystallization regulation and activation of the PPARα pathway https://www.biorxiv.org/content/10.1101/2022.12.05.519215v1?med=mas